ABOUT INDEXING BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S PAGE NEWS, EVENTS CONTACT
REVISTA DE CHIMIE
Cite as: Rev. Chim.
https://doi.org/10.37358/Rev.Chim.1949

OSIM Nr. R102355
ISSN Print 0034-7752
ISSN Online 2668-8212
Journal Metrics
* Impact Factor 2019: 1.755
* 5-Year IF: 1.351
* CiteScore: 2.2
* H index: 28
(InCites Journal Citation Reports)

REVISTA DE CHIMIE Latest Issue

LATEST ISSUE >>>

   Volume 71, 2020
   Volume 70, 2019
   Volume 69, 2018
   Volume 68, 2017
   Volume 67, 2016
   Volume 66, 2015
   Volume 65, 2014
   Volume 64, 2013
   Volume 63, 2012
   Volume 62, 2011
   Volume 61, 2010
   Volume 60, 2009
   Volume 59, 2008
   Volume 58, 2007
 
<<<< back

Revista de Chimie (Rev. Chim.), Year 2015, Volume 66, Issue 1,





JENEL MARIAN PATRASCU, RADU PREJBEANU, VOICHITA LAZUREANU, SIMONA NITESCU, HORIA HARAGUS, GRATIAN DAMIAN, DINU VERMESAN
Selective Use of Low Dose Tranexamic Acid in Orthopedic Surgery

Abstract:

Tranexamic acid, a synthetic derivative of lysine, is the most commonly used antifibrinolytic agent to reduce blood loss associated with surgical procedures. The regimens and routes used are highly variable. There is a current shift from systemic (intravenous) use towards topical instillation and periarticular injections. We aimed to analyze the efficacy and safety for selective use of low dose tranexamic acid in major orthopedic surgery. The use of tranexamic acid (Exacyl) was retrospectively reviewed from our Hospital’s electronic database. Over a period of 12 months, a number of 46 surgeries in 45 patients were identified, with a mean age was 66 years old. An average of 1.17 units of tranexamic acid (500mg/5mL) were used per case (range 1-3). The drug was administered immediately postoperatively and if necessary repeated once after 8-24 h. The maximum dose per administration was 10mg/kg body weight, with a mean of 7.3 (SD 1.92). The average drop in hemoglobin (from preoperative to lowest consecutive postoperative) was 2.55 (range 0.1-5.8, median 1.3). 22/46 of surgeries required transfusions, with an average of 1.8 red blood cell mass per case (range 1-4). The average duration of postoperative hospital stay was 13 days (range 7-25). There were no complications directly related to tranexamic acid administration. Even in low dose, postoperative intravenous administration of tranexamic acid reduces total blood loss and requirements for transfusion. Key words: tranexamic acid, total knee arthroplasty, hip replacement, blood loss

Issue: 2015, Volume 66, Issue 1
Pages:
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
 
<<<< back
 
PUBLISHING SECTION
Author Guidelines
 * Paper Drafting
 * Paper Template
 * Ethical Statement
 * Paper Submission
 * Author Payments
Ghidul Autorului (ro)
Submit Paper
Author's Page
Publishing Ethics
Peer Review Process
Open Access & Archiving Policy
 Search Authors
 LATEST NEWS
REvista de Chimie Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
dictionar English-Romanian Dictionary for Mechanical Engineering
(download pdf)
  News, Events
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License
 Conferences of Contemporary
 Chemistry
 Biblioteca Chimiei
 Materiale Plastice